GLP-1 weight loss treatments for all genders

GLP-1 weight loss treatments, backed by science.

Achieve sustainable weight loss with doctor-guided GLP-1 treatments, including semaglutide and tirzepatide.

Get Started

GLP-1 + GIP

Tirzepatide

Discover the most effective weight loss tool on the market – proven to help shed an average of 20.8% of body weight in 67 weeks.*

Tirzepatide prescription

Tirzepatide

Customized dose for metabolic benefits and weight loss. Ideal for effective, targeted results.

Proven to lose weight effectively

Choose between starter packs or custom dosing

Free and discreet shipping

Starting at $132.99/mo

Tirzepatide Microdose prescription

Tirzepatide Microdose

Customized lower dose for metabolic benefits and controlled weight loss. Ideal for gentle, targeted results.

Sustainable results

Lower risk of side effects

Free and discreet shipping

Starting at $99.99/mo

Tirzepatide prescription

Tirzepatide

Customized dose for metabolic benefits and weight loss. Ideal for effective, targeted results.

Proven to lose weight effectively

Choose between starter packs or custom dosing

Free and discreet shipping

Starting at $132.99/mo

Tirzepatide Microdose prescription

Tirzepatide Microdose

Customized lower dose for metabolic benefits and controlled weight loss. Ideal for gentle, targeted results.

Sustainable results

Lower risk of side effects

Free and discreet shipping

Starting at $99.99/mo

GLP-1

Semaglutide

Unlock a slimmer you with Semaglutide, proven to help shed an average of 16.5% body weight in 70 weeks.*

Semaglutide prescription

Semaglutide

Customized dose for metabolic benefits and weight loss. Ideal for effective, targeted results.

Proven to lose weight effectively

Choose between starter packs or custom dosing

Free and discreet shipping

Starting at $99.99/mo

Semaglutide Microdose prescription

Semaglutide Microdose

Customized lower dose for metabolic benefits and controlled weight loss. Ideal for gentle, targeted results.

Sustainable results

Lower risk of side effects

Free and discreet shipping

Starting at $79.99/mo

Semaglutide prescription

Semaglutide

Customized dose for metabolic benefits and weight loss. Ideal for effective, targeted results.

Proven to lose weight effectively

Choose between starter packs or custom dosing

Free and discreet shipping

Starting at $99.99/mo

Semaglutide Microdose prescription

Semaglutide Microdose

Customized lower dose for metabolic benefits and controlled weight loss. Ideal for gentle, targeted results.

Sustainable results

Lower risk of side effects

Free and discreet shipping

Starting at $79.99/mo

*Maximus clinical study data on Maximus clients

Proven ingredients. Proven results.

Get Started

body weight using Semaglutide

↓16.5%

Maximus clinical trials have shown that Semaglutide can help individuals lose up to 16.5% of their body weight over 67 weeks.

body weight using Tirzepatide

↓20.8%

Maximus clinical trials have shown that Tirzepatide can help individuals lose up to 20.8% of their body weight over 70 weeks.

Appetite reduction using GLP-1

↓92.4%

While using a GLP-1, 92.4% of Maximus clients report appetite reduction

Nearly 74% of adults in the U.S. are overweight or obese.

Adjust the scale to view your potential weight loss.

your current weight (lbs):

270

in one year you could lose (lbs):

45

Optimize your long-term health

obesity can cause

Type 2 diabetes

Is your health goal now to get your Type 2 diabetes under control?

Get Started

obesity is tied to

Heart Disease

How can we help you decrease your risk of heart disease (including stroke)?

Get Started

obesity can cause

Certain cancers

How can you be more proactive and decrease your risk of certain cancers?

Get Started

Weight Loss Treatment FAQs

Contact Support

Who is eligible for GLP-1 weight loss treatment?

GLP-1 weight loss medications may be appropriate if you’re trying to lose weight, reduce appetite, improve blood sugar control, or support long-term metabolic health.

After you sign up, a Maximus doctor will review your medical history and determine whether Tirzepatide or Semaglutide is safe and appropriate for you.

If you’re not approved for treatment, you’ll receive a full refund (minus the cost of the doctor consultation).

What states is Weight Loss Protocol available in?

Our Weight Loss Protocol — including Semaglutide, Tirzepatide, and microdose options — is available nationwide in all 50 states and Washington, DC.

Can I use my HSA or FSA card to pay for Weight Loss Protocol?

Yes. Maximus accepts both HSA and FSA cards for weight loss treatment.

Simply enter your HSA/FSA card information at checkout as you would any debit or credit card.

Coverage varies by plan, so if you're unsure whether your HSA/FSA approves GLP-1 medications, check with your plan administrator.

If I’ve previously been prescribed GLP-1 medication, can I start at the same dosage with Maximus?

If you have documentation of prior GLP-1 use, your Maximus provider will help determine the most appropriate dose for your treatment plan.

Note: The 90-day starter pack comes with a predetermined dose and cannot be adjusted.

Do you charge extra for higher doses?

We offer multiple plan types depending on your needs:

- Flat-rate monthly plans that include access to all dose tiers
- Quarterly plans that ship a three-month supply of a tailored dose

Your Maximus provider will help you determine the safest and most effective dose for your goals.

What side effects should I be aware of?

Common side effects of GLP-1 medications include:

- Nausea
- Diarrhea
- Vomiting
- Constipation

Side effects are typically mild and temporary. If you experience discomfort, your Maximus doctor may adjust your dosing schedule or recommend supportive strategies.

How long until I see results?

Most people notice:

- Reduced appetite within the first few days
- More stable cravings within 1–2 weeks
- Visible weight loss within several weeks once medication reaches steady-state levels

Results vary based on your dose, metabolism, and adherence to habits like diet and physical activity.

Are GLP-1 medications safe for long-term use?

GLP-1s like Semaglutide and Tirzepatide have been extensively studied for long-term use in weight, metabolic, and diabetes management.

Your Maximus provider will monitor your health markers and adjust your treatment plan as needed.

Can this be used with other Maximus Protocols?

Yes. The Weight Loss Protocol works well alongside other Maximus protocols -including Testosterone, Hair Growth, Blood Flow, and Oxytocin Calming Cream — as part of a comprehensive health optimization plan.

Your provider will ensure there are no contraindications.

Is the Weight Loss Protocol available for both men and women?

Yes — Maximus weight loss treatments are available and effective for both men and women.

Is this compounded with base form or salt form?

Maximus uses only the base form of Semaglutide and Tirzepatide — the same form studied, tested, and approved in clinical trials.

Some pharmacies use salt forms (e.g., “Semaglutide Sodium” or “Semaglutide Acetate”), which are different chemicals, are not equivalent, and have not been tested for safety or effectiveness.

Using salt-form compounds may be unsafe or ineffective.

1
Weight loss, whether achieved by lifestyle intervention, pharmacotherapy, or bariatric surgery, is highly effective as a primary interventional strategy in both the prevention and treatment of type 2 diabetes. In high-risk patients with prediabetes and/or metabolic syndrome, weight loss effectively prevents progression to type 2 diabetes mellitus (T2DM) and improves cardiovascular risk factors.
2
Intentional weight loss, accomplished through behavioral weight loss and exercise, improves insulin sensitivity and associated cardio-metabolic risk factors such as lipid measures, blood pressure, measures of inflammation and vascular function both in healthy individuals and patients with CHD. Additionally, physical fitness, physical function and quality of life all improve.
3
According to IARC data, high BMI index may be the cause of up to half a million cancer cases per year. In addition, overweight and obesity contribute to increased mortality due to malignancies - it is estimated that they are the cause of death in 20% of women and in 14% of men. Data from the American Cancer Society indicate increased mortality due to pancreatic cancer, liver cancer, multiple myeloma, and Hodgkin's lymphoma in connection with the occurrence of excessive body weight.
4
In the SELECT cardiovascular outcomes trial, semaglutide showed a 20% reduction in major adverse cardiovascular events in 17,604 adults with preexisting cardiovascular disease, overweight or obesity, without diabetes.

* These statements have not been evaluated by the Food and Drug Administration. This product is not intended to diagnose, treat, cure, or prevent any disease. Compounded medications are not approved or evaluated for safety, efficacy, or quality by the FDA.